Novavax Inc (NASDAQ:NVAX)

8.87
Delayed Data
As of May 22
 +0.01 / +0.11%
Today’s Change
3.92
Today|||52-Week Range
9.95
+49.58%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues14.7M22.1M20.9M30.7M
 
 
 
 
 
Cost of Goods Sold5.4M13.0M5.6M10.6M
 
 
 
 
 
Depreciation And Amortization1.6M1.7M2.6M4.4M
 
 
 
 
 
 
Operating ExpensesGross Income7.7M7.4M12.7M15.7M
 
 
 
 
 
General Expenses29.3M37.0M63.8M99.4M
 
 
 
 
 
Research And Development17.9M26.1M50.3M79.4M
 
 
 
 
 
Total Operating Expenses36.3M51.7M72.0M114.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-21.6M-29.7M-51.1M-83.7M
 
 
 
 
 
Extraordinary Credit2.5M101.0K267.0K--
 
 
 
 
Extraordinary Charge0.000.00-1.3M--
 
 
Interest Expense On Debt9.0K32.0K160.0K157.0K
 
 
 
 
 
Other Expenses26.0K924.0K182.0K615.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.0M-28.5M-52.0M-82.9M
 
 
 
 
 
Income Taxes-412.0K0.00-25.0K0.00
 
 
 
Net Income-19.4M-28.5M-52.0M-82.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS113.6M131.7M169.7M225.8M
 
 
 
 
 
Shares To Calculate EPS Diluted113.6M131.7M169.7M225.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.17-$0.22-$0.31-$0.37
 
 
 
 
 
EPS Diluted-$0.17-$0.22-$0.31-$0.37
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account